当前位置： SCI文献检索 > BLOOD期刊下所有文献 > Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.

Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.

Abstract：

:Monoclonal gammopathy of undetermined significance (MGUS) is present in ∼2% of individuals age >50 years. The increased risk of multiple myeloma (MM) in relatives of individuals with MGUS is consistent with MGUS being a marker of inherited genetic susceptibility to MM. Common single-nucleotide polymorphisms (SNPs) at 2p23.3 (rs6746082), 3p22.1 (rs1052501), 3q26.2 (rs10936599), 6p21.33 (rs2285803), 7p15.3 (rs4487645), 17p11.2 (rs4273077), and 22q13.1 (rs877529) have recently been shown to influence MM risk. To examine the impact of these 7 SNPs on MGUS, we analyzed two case-control series totaling 492 cases and 7306 controls. Each SNP independently influenced MGUS risk with statistically significant associations (P < .02) for rs1052501, rs2285803, rs4487645, and rs4273077. SNP associations were independent, with risk increasing with a larger number of risk alleles carried (per allele odds ratio, 1.18; P < 10(-7)). Collectively these data are consistent with a polygenic model of disease susceptibility to MGUS.

journal_name

Blood

journal_title

Blood

authors

Weinhold N,Johnson DC,Rawstron AC,Försti A,Doughty C,Vijayakrishnan J,Broderick P,Dahir NB,Begum DB,Hosking FJ,Yong K,Walker BA,Hoffmann P,Mühleisen TW,Langer C,Dörner E,Jöckel KH,Eisele L,Nöthen MM,Hose D,Davies

doi

10.1182/blood-2013-10-532283

subject

Has Abstract

pub_date

2014-04-17 00:00:00

pages

2513-7; quiz 2593

issue

16

eissn

0006-4971

issn

1528-0020

pii

blood-2013-10-532283

journal_volume

123

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh(o)(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients.

    abstract：:Rh(o)(D) immune globulin intravenous (anti-D IGIV) was licensed by the United States Food and Drug Administration (FDA) in March 1995 to treat patients with immune thrombocytopenic purpura (ITP). Anti-D IGIV induces extravascular hemolysis, an expected adverse reaction that is consistent with the presumed mechanism of...

    journal_title：Blood

    pub_type： 杂志文章,评审

    doi：

    authors： Gaines AR

    更新日期：2000-04-15 00:00:00

  • The gene for the alpha 4 subunit of the VLA-4 integrin maps to chromosome 2Q31-32.

    abstract：:The VLA-4 integrin (CD49d/CD29), initially discovered on lymphoid cells, is actually known to be highly expressed on T cells, B cells, monocytes, and derived cell lines. Unlike other VLA integrins, mainly involved in cell-matrix adhesive interactions, VLA-4 has also been implicated in several cellular interactions. Ba...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Zhang ZH,Vekemans S,Aly MS,Jaspers M,Marynen P,Cassiman JJ

    更新日期：1991-11-01 00:00:00

  • Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1.

    abstract：:We analyzed the expression of myelomonocytic-associated antigens on lymphocytes from B cell chronic lymphocytic leukemia (B-CLL) patients. Blood mononuclear cells were depleted of monocytes by one-step Percoll density gradient centrifugation and tested for antigen expression by fluorescent microscopy and flow cytometr...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Morabito F,Prasthofer EF,Dunlap NE,Grossi CE,Tilden AB

    更新日期：1987-12-01 00:00:00

  • The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.

    abstract：:Transplant-associated thrombotic microangiopathy (TA-TMA) occurs frequently after hematopoietic stem cell transplantation (HSCT) and can lead to significant morbidity and mortality. There are no data addressing individual susceptibility to TA-TMA. We performed a hypothesis-driven analysis of 17 candidate genes known t...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2015-08-663435

    authors： Jodele S,Zhang K,Zou F,Laskin B,Dandoy CE,Myers KC,Lane A,Meller J,Medvedovic M,Chen J,Davies SM

    更新日期：2016-02-25 00:00:00

  • Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells.

    abstract：:Tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 are proteins with proteinase-inhibiting and cytokine properties. TIMP-1 is active primarily in B cells and B-cell lymphomas, whereas TIMP-2 expression is restricted to T cells. The expression of TIMP-1 and TIMP-2 in lymph nodes from patients with Hodgkin disea...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood.v99.1.258

    authors： Oelmann E,Herbst H,Zühlsdorf M,Albrecht O,Nolte A,Schmitmann C,Manzke O,Diehl V,Stein H,Berdel WE

    更新日期：2002-01-01 00:00:00

  • Platelet modulation of polymorphonuclear leukocyte shear induced aggregation.

    abstract：:A cone and plate viscometer and Coulter Counter were used to study platelet modulation of polymorphonuclear leukocyte (PMNL) aggregation caused by controlled shear stress. As an index of aggregation, the large-particle percentage (LPP) was calculated. This represents the ratio of aggregated cell count to total cell co...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Rhee BG,Hall ER,McIntire LV

    更新日期：1986-01-01 00:00:00

  • Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire.

    abstract：:The human peripheral B-cell compartment displays a large population of immunoglobulin M-positive, immunoglobulin D-positive CD27(+) (IgM(+)IgD(+)CD27(+)) "memory" B cells carrying a mutated immunoglobulin receptor. By means of phenotypic analysis, complementarity-determining region 3 (CDR3) spectratyping during a T-in...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2004-01-0346

    authors： Weller S,Braun MC,Tan BK,Rosenwald A,Cordier C,Conley ME,Plebani A,Kumararatne DS,Bonnet D,Tournilhac O,Tchernia G,Steiniger B,Staudt LM,Casanova JL,Reynaud CA,Weill JC

    更新日期：2004-12-01 00:00:00

  • The tumor marker Fascin is strongly induced by the Tax oncoprotein of HTLV-1 through NF-kappaB signals.

    abstract：:Oncogenic transformation of CD4(+) T cells by human T-cell lymphotropic virus type 1 (HTLV-1) is understood as the initial step to adult T-cell leukemia/lymphoma, a process that is mainly initiated by perturbation of cellular signaling by the viral Tax oncoprotein, a potent transcriptional regulator. In search of nove...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2010-09-305805

    authors： Kress AK,Kalmer M,Rowan AG,Grassmann R,Fleckenstein B

    更新日期：2011-03-31 00:00:00

  • Immunoproteasome down-modulation enhances the ability of dendritic cells to stimulate antitumor immunity.

    abstract：:The process of dendritic cell (DC) maturation, critical for effective DC-based immunotherapy, also alters the proteasome such that peptides presented in the context of HLA class I are generated not by the constitutive proteasome, but by the immunoproteasome. Cytotoxic T lymphocytes (CTLs) induced by such DCs might not...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2007-04-083188

    authors： Dannull J,Lesher DT,Holzknecht R,Qi W,Hanna G,Seigler H,Tyler DS,Pruitt SK

    更新日期：2007-12-15 00:00:00

  • Blood tests for the diagnosis of venous and arterial thrombosis.

    abstract：:There are many reports in the literature of blood test abnormalities occurring in patients with venous or arterial thrombosis. Most of these have not used acceptable criteria for establishing an association between thrombosis and blood tests and, therefore, their interpretation is questionable. Recently, sensitive and...

    journal_title：Blood

    pub_type： 杂志文章,评审

    doi：

    authors： Hirsh J

    更新日期：1981-01-01 00:00:00

  • Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.

    abstract：:Chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm with variable clinical course. To predict the clinical outcome, we previously developed a CMML-specific prognostic scoring system (CPSS) based on clinical parameters and cytogenetics. In this work, we tested the hypothesis that acc...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2016-05-714030

    authors： Elena C,Gallì A,Such E,Meggendorfer M,Germing U,Rizzo E,Cervera J,Molteni E,Fasan A,Schuler E,Ambaglio I,Lopez-Pavia M,Zibellini S,Kuendgen A,Travaglino E,Sancho-Tello R,Catricalà S,Vicente AI,Haferlach T,Haferlach

    更新日期：2016-09-08 00:00:00

  • von Willebrand factor (VWF) propeptide binding to VWF D'D3 domain attenuates platelet activation and adhesion.

    abstract：:Noncovalent association between the von Willebrand factor (VWF) propeptide (VWFpp) and mature VWF aids N-terminal multimerization and protein compartmentalization in storage granules. This association is currently thought to dissipate after secretion into blood. In the present study, we examined this proposition by qu...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-10-387548

    authors： Madabhushi SR,Shang C,Dayananda KM,Rittenhouse-Olson K,Murphy M,Ryan TE,Montgomery RR,Neelamegham S

    更新日期：2012-05-17 00:00:00

  • c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia.

    abstract：:Low-dose interferon-alpha (IFN-alpha) therapy is consistently effective in the treatment of hairy cell leukemia (HCL). In two cases of resistance to IFN-alpha administration, we diagnosed variant HCL, a form of HCL with intermediate features between typical HCL and B cell prolymphocytic leukemia. We tried to distingui...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Lehn P,Sigaux F,Grausz D,Loiseau P,Castaigne S,Degos L,Flandrin G,Dautry F

    更新日期：1986-10-01 00:00:00

  • Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

    abstract：:A series of alterations in the cellular genome affecting the expression or function of genes controlling cell growth and differentiation is considered to be the main cause of cancer. These mutational events include activation of oncogenes and inactivation of tumor suppressor genes. The elucidation of human cancer at t...

    journal_title：Blood

    pub_type： 杂志文章,评审

    doi：

    authors： Reuter CW,Morgan MA,Bergmann L

    更新日期：2000-09-01 00:00:00

  • Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.

    abstract：:To assess the influence of graft-versus-host disease (GVHD) on recurrent leukemia and survival after allogeneic marrow transplantation, we studied 1,202 patients with acute nonlymphocytic leukemia (ANL), acute lymphocytic leukemia (ALL), and chronic myelogenous leukemia (CML) given unmodified marrow grafts from HLA-id...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Sullivan KM,Weiden PL,Storb R,Witherspoon RP,Fefer A,Fisher L,Buckner CD,Anasetti C,Appelbaum FR,Badger C

    更新日期：1989-05-01 00:00:00

  • Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the i

    abstract：:Anacardic acid (6-pentadecylsalicylic acid) is derived from traditional medicinal plants, such as cashew nuts, and has been linked to anticancer, anti-inflammatory, and radiosensitization activities through a mechanism that is not yet fully understood. Because of the role of nuclear factor-kappaB (NF-kappaB) activatio...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2007-10-117994

    authors： Sung B,Pandey MK,Ahn KS,Yi T,Chaturvedi MM,Liu M,Aggarwal BB

    更新日期：2008-05-15 00:00:00

  • Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.

    abstract：:Over the past few years, substantial advances have been made in understanding the pathogenesis, evolution, and complexity of mast cell neoplasms. New diagnostic and prognostic parameters and novel therapeutic targets with demonstrable clinical impact have been identified. Several of these new markers, molecular target...

    journal_title：Blood

    pub_type： 杂志文章,评审

    doi：10.1182/blood-2016-09-731893

    authors： Valent P,Akin C,Metcalfe DD

    更新日期：2017-03-16 00:00:00

  • Pim2 cooperates with PML-RARalpha to induce acute myeloid leukemia in a bone marrow transplantation model.

    abstract：:Although the potential role of Pim2 as a cooperative oncogene has been well described in lymphoma, its role in leukemia has remained largely unexplored. Here we show that high expression of Pim2 is observed in patients with acute promyelocytic leukemia (APL). To further characterize the cooperative role of Pim2 with p...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2009-03-210070

    authors： Agrawal-Singh S,Koschmieder S,Gelsing S,Stocking C,Stehling M,Thiede C,Thoennissen NH,Köhler G,Valk PJ,Delwel R,Mills K,Bäumer N,Tickenbrock L,Hansen K,Berdel WE,Müller-Tidow C,Serve H

    更新日期：2010-06-03 00:00:00

  • Interleukin-6 (IL-6) is an intermediate in IL-1-induced proliferation of leukemic human megakaryoblasts.

    abstract：:We have examined the in vitro effects of recombinant human (rh) interleukin-1 (IL-1) on the growth of purified megakaryoblasts obtained from patients with acute megakaryoblastic leukemia. We demonstrate that both IL-1 alpha and IL-1 beta treatment of these cells led to stimulation of DNA synthesis (as shown by increas...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Brach MA,Löwenberg B,Mantovani L,Schwulera U,Mertelsmann R,Herrmann F

    更新日期：1990-11-15 00:00:00

  • Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP.

    abstract：:Immune thrombocytopenias are usually associated with normal or increased numbers of megakaryocytes in the marrow. Therefore, the mechanism(s) responsible for the destruction of circulating platelets may not affect megakaryocytes in the same way. One of the possibilities which could account for the differential effect ...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Stahl CP,Zucker-Franklin D,McDonald TP

    更新日期：1986-02-01 00:00:00

  • Autosomal-dominant giant platelet syndromes: a hint of the same genetic defect as in Fechtner syndrome owing to a similar genetic linkage to chromosome 22q11-13.

    abstract：:Families with 3 different syndromes characterized by autosomal dominant inheritance of low platelet count and giant platelets were studied. Fechtner syndrome is an autosomal-dominant variant of Alport syndrome manifested by nephritis, sensorineural hearing loss, and cataract formation in addition to macrothrombocytope...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Toren A,Rozenfeld-Granot G,Rocca B,Epstein CJ,Amariglio N,Laghi F,Landolfi R,Brok-Simoni F,Carlsson LE,Rechavi G,Greinacher A

    更新日期：2000-11-15 00:00:00

  • HIT-antibodies promote their own antigen.

    abstract：:Antiplatelet factor 4 (PF4) antibodies have an important role in the most frequent drug-induced immune disorder, heparin-induced thrombocytopenia (HIT). In this issue of Blood, Sachais and coworkers propose a new feature that may explain why only some anti-PF4 antibodies are pathogenic.(1) In addition to epitope speci...

    journal_title：Blood

    pub_type： 评论,杂志文章

    doi：10.1182/blood-2012-06-430694

    authors： Greinacher A,Krauel K,Jensch I

    更新日期：2012-08-02 00:00:00

  • Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum.

    abstract：:IL-15 is an important cytokine for the function of the immune system, but the form(s) of IL-15 produced in the human body are not fully characterized. Coexpression of the single-chain IL-15 and the IL-15 receptor alpha (IL-15Rα) in the same cell allows for efficient production, surface display, and eventual cleavage a...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-10-384362

    authors： Bergamaschi C,Bear J,Rosati M,Beach RK,Alicea C,Sowder R,Chertova E,Rosenberg SA,Felber BK,Pavlakis GN

    更新日期：2012-07-05 00:00:00

  • Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures.

    abstract：:To characterize juvenile chronic myelogenous leukemia (JCML), the proliferative properties of bone marrow (BM) and peripheral blood (PB) cells from nine patients were studied using assays for CFU-C and CFU-GEMM and liquid cultures. All specimens showed two reproducible abnormalities: impaired growth of normal hematopo...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Estrov Z,Grunberger T,Chan HS,Freedman MH

    更新日期：1986-05-01 00:00:00

  • How I treat acute myeloid leukemia in the era of new drugs.

    abstract：:The acute myeloid leukemia (AML) treatment landscape has changed substantially since 2017. New targeted drugs have emerged, including venetoclax to target B-cell lymphoma 2, midostaurin and gilteritinib to target FLT3, and ivosidenib and enasidenib to target mutant isocitrate dehydrogenase 1 and 2, respectively. Other...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood.2019001239

    authors： DiNardo CD,Wei AH

    更新日期：2020-01-09 00:00:00

  • Function of wild-type or mutant Rac2 and Rap1a GTPases in differentiated HL60 cell NADPH oxidase activation.

    abstract：:Studies of neutrophil nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation in a cell-free system showed that the low molecular-weight guanosine triphosphatase (GTPase) Rac was required, and that Rap1a may participate in activation of the catalytic complex. Full-length posttranslationally modified Rac...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Gabig TG,Crean CD,Mantel PL,Rosli R

    更新日期：1995-02-01 00:00:00

  • Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.

    abstract：:The majority of diffuse large B-cell lymphoma (DLBCL) tumors contain mutations in histone-modifying enzymes (HMEs), indicating a potential therapeutic benefit of histone deacetylase inhibitors (HDIs), and preclinical data suggest that HDIs augment the effect of rituximab. In this randomized phase 2 study, we evaluated...

    journal_title：Blood

    pub_type： 杂志文章,多中心研究

    doi：10.1182/blood-2016-02-699520

    authors： Assouline SE,Nielsen TH,Yu S,Alcaide M,Chong L,MacDonald D,Tosikyan A,Kukreti V,Kezouh A,Petrogiannis-Haliotis T,Albuquerque M,Fornika D,Alamouti S,Froment R,Greenwood CM,Oros KK,Camglioglu E,Sharma A,Christodoulopoul

    更新日期：2016-07-14 00:00:00

  • Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.

    abstract：:There is now strong experimental evidence that tissue factor pathway inhibitor (TFPI) is a critical inhibitor to modulate tissue factor-induced coagulation, but the role of TFPI as a risk factor for thrombosis is yet to be to be determined. This study investigated the role of low TFPI levels for the development of dee...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2002-10-3188

    authors： Dahm A,Van Hylckama Vlieg A,Bendz B,Rosendaal F,Bertina RM,Sandset PM

    更新日期：2003-06-01 00:00:00

  • Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma.

    abstract：:Daratumumab targets CD38-expressing myeloma cells through a variety of immune-mediated mechanisms (complement-dependent cytotoxicity, antibody-dependent cell-mediated cytotoxicity, and antibody-dependent cellular phagocytosis) and direct apoptosis with crosslinking. These mechanisms may also target nonplasma cells tha...

    journal_title：Blood

    pub_type： 杂志文章,多中心研究

    doi：10.1182/blood-2015-12-687749

    authors： Krejcik J,Casneuf T,Nijhof IS,Verbist B,Bald J,Plesner T,Syed K,Liu K,van de Donk NW,Weiss BM,Ahmadi T,Lokhorst HM,Mutis T,Sasser AK

    更新日期：2016-07-21 00:00:00

  • Characterization of nuclear factors that bind to a critical positive regulatory element of the human granulocyte-macrophage colony-stimulating factor promoter.

    abstract：:Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic growth factor that stimulates the proliferation, maturation, and functional activity of myeloid cells in peripheral blood and bone marrow. Expression of GM-CSF is tightly regulated and is limited to cells stimulated directly (T cells, macroph...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Fraser JK,Tran S,Nimer SD,Gasson JC

    更新日期：1994-10-15 00:00:00